Oral vaccine in otosclerosis

Medical Hypotheses

Volumn 54, Issue 2, 2000, Pages 216-220

  Lopez Gonzalez, M A ^a   Delgado, F ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN ANTIBODY; COLLAGEN TYPE 2; VACCINE;

ACOUSTIC REFLEX; AUTOIMMUNE DISEASE; DESENSITIZATION; FAMILY HISTORY; HUMAN; OTOSCLEROSIS; PRIORITY JOURNAL; REVIEW;

EID: 0034018801     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.1999.0024     Document Type: Article

References (52)

1. Larson A. Otosclerosis. A genetic and clinical study. Acta Otolaryngol. 1960.
2. Causse J. R., Causse J. B., Bretlau P. Etiology of otospongiotic sensorineural hearing losses. Am J Otol. 10:1989;99-107.
3. Altman F. The inner ear in genetically determined deafness. Acta Otolaryngol. 187:1963;1-39.
4. Morrison A. W. Genetic factors in otosclerosis. Ann R Coll Surg Eng. 41:1967;202-237.
5. Arnold W., Friedmann I. Immunochemistry of otosclerosis. Acta Otolaryngol. 470:1990;124-128.
6. Niedermeyer H. P., Arnold W. Otosclerosis: a measles virus associated inflammatory disease. Acta Otolaryngol. 115:1995;300-303.
7. Gamir M. A., Mallea I., Marco J., Rubio F., Orts M. Human leukocyte antigen and otosclerosis. Acta Otorrinolaring Esp. 47:1996;26-28.
8. Arnold W., Altermatt H. J., Gebbers J. O., Laissuel J. Secretory immunoglobulin A in the human endolymphatic sac. ORL. 46:1984;286-288.
9. Harris J. P. Immunology of the inner ear. Evidence of local antibody production. Ann Otol Rhinol Laryngol. 93:1984;157-162.
10. Tomiyama S., Harris J. P. The endolymphatic sac. Its importance in inner ear immune response. Laryngoscope. 96:1986;685-691.
11. Lim J. D., Robinson M., Saunders W. H. Morphologic and immunohistochemical observations of otosclerotic stapes. Am J Otolaryngol. 8:1987;282-295.
12. Altermatt H. J., Gebbers J. O., Arnold W., Laissue J. The epithelium of the human endolymphatic sac. Immunochemical characterization. ORL. 52:1990;113-120.
13. Gloddek B., Ryan A. F., Harris J. P. Homing of lymphocytes to the inner ear. Acta Otolaryngol. 111:1991;1051-1059.
14. Yoo T. J. Etiopathogenesis of otosclerosis: a hypothesis. Ann Otol Rhinol Laryngol. 93:1984;28-33.
15. Causse J. R., Causse J. B. Otospongiosis as a genetic disease. Early detection, medical management, and prevention. Am J Otol. 5:1984;211-223.
16. Kennedy D. W., Hoffer M. E., Holliday M. The effects of etidronate disodium on progressive hearing loss from otosclerosis. Otolaryngol Head Neck Surg. 109:1993;461-467.
17. Causse J. R., Causse J. B. Early detection of otosclerosis by impedance audiometry screening. Scand Audiol. 17:1983;47-54.
18. Metz O. Threshold of reflex contractions of muscles of the middle ear recruitment of loudness. Arch Otolaryngol. 55:1952;536-543.
19. Anderson H., Barr B., Wedenberg E. Early diagnosis of VIII nerve tumors by acoustic reflex tests. Acta Otolaryngol. 263:1970;232-237.
20. Jerger J., Jerger S., Hauldin L. Studies in impedance audiometry. I. Normal and sensorineural ears. Arch Otolaryngol. 96:1972;513-523.
21. Terkildsen K., Osterhammel P., Bretlau P. Acoustic middle ear muscle reflexes in patients with otosclerosis. Arch Otolaryngol. 98:1973;152-155.
22. Jerger J., Anthony L., Jerger S. Studies in impedance audiometry. III. Middle ear disorders. Arch Otolaryngol. 99:1973;165-171.
23. Causse J., Bel J., Michaux P., Vernieres J. Essai d'explication de l'effect on-off dans I'otospongiose. Ann Otol. 91:1974;491-510.
24. Yoo T. J., Stuart J. M., Kang A. H., Townes A. S., Tomoda K., Dixit S. Type II collagen autoimmunity in otosclerosis and Ménière's disease. Science. 217:1982;1153-1154.
25. Yoo T. J., Tomoda K., Stuart J. M., Kang A. H., Townes A. S. Type II collagen-induced autoimmune otospongiosis, A preliminary report. Ann Otol Rhinol Laryngol. 92:1983;103-108.
26. Huang C. C., Yi Z., Abramson M. Type II collagen-induced otospongiosis-like lesions in rats. Am J Otolaryngol. 7:1986;258-266.
27. Huang C. C., Yabe Y., Yan S. D. Effects of indomethacin and calcitonin on bone absorption in type II-collagen-induced otosclerosis-like lesions in rats. Otolaryngol Head Neck Surg. 103:1991;1002-1008.
28. Schiff M. Immunologic aspects of otologic disease. Bow C. A., Siminovitch K. A., Zanetti M., Theofilopoulus A. N. N. N. The Molecular Pathology of Autoimmune Diseases. 1993;715-724 Raven Press, New York.
29. Sorensen M. S., Nielsen L. P., Bretlau P., Jorgensen M. B. The role of type II collagen autoimmunity in otosclerosis revisited. Acta Otolaryngol. 105:1988;242-247.
30. Helfgott S. M., Moscicki R. A., San Martin J. Correlation between antibodies to type II collagen and treatment outcome in bilateral progressive sensorineural hearing loss. Lancet. 337:1991;387-389.
31. Joliat T., Seyer J., Berstein J. Antibodies against a 30 kilodaltons cochlear protein and type II and IX collagens in the serum of patients with inner ear diseases. Ann Otol Rhinol Laryngol. 101:1992;1000-1006.
32. Sutjita M., Peter J. B., Baloh R. W., Oas J. G., Laurent C., Nordang L. Type II collagen antibodies in patients with sensorineural hearing loss. Lancet. 339:1992;559-560.
33. Bujia J., Burmester G. Presence of autoantibodies against specific cartilage collagens of otosclerotic patients. Acta Otorrinolaring Esp. 44:1993;277-280.
34. Michaelsson E., Malmstrom V., Reis S., Engstrom A., Burkhardt H., Holmdahl R. T cell recognition of carbohydrates on type II collagen. J Exp Med. 180:1994;745-749.
35. Hughes G. B., Barna B. P., Kinney S. E., Calabresse L. H., Nalepa N. L. Predictive value of laboratory tests in 'autoimmune' inner ear disease: preliminary report. Laryngoscope. 96:1986;502-505.
36. Lejeune J. M., Charachon R. New immunobiological tests in the investigation of Ménière disease and sensorineural hearing loss. Acta Otolaryngol. 112:1992;174-179.
37. Charachon R., Lejeune J. M., Salomon P., Lavieille J. P., Briand C. Apport des tests de transformation lymphoblastique et d'immunofluorescence indirecte au diagnostic des surdités auto-immunes chez I'homme. Revue Laryngologie. 115:1994;171-177.
38. Berger P., Hillman M., Tabak M., Vollrath M. The lymphocyte transformation test with type II collagen as a diagnostic tool of autoimmune sensorineural hearing loss. Laryngoscope. 101:1991;895-899.
39. Nagler-Anderson C., Bober L. A., Robinson M. E., Siskind G. W., Thorbecke G. J. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci USA. 83:1986;7443-7446.
40. Zhang Z. J., Lee C. S. Y., Lider O., Weiner H. L. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J Immunol. 154:1990;2489-2493.
41. Trentham D. E., Dynesius-Trentham R. A., Orav E. J. Effects of oral administration of type II collagen on rheumatoid arthritis. Science. 261:1993;1727-1730.
42. Bitar D. M., Whitacre C. C. Suppression of experimental encephalomyelitis by the oral administration of myelin basic protein. Cel Immunol. 112:1988;364-370.
43. Higgins P. J., Weiner H. L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol. 140:1988;440-445.
44. Miller A., Lider O., Weiner H. L. Antigen-driven bystander suppression after oral administration of antigens. J Exp Med. 174:1991;791-798.
45. Whitacre C. C., Gienapp I. E., Orosz C. G., Bitar D. M. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol. 147:1991;2155-2163.
46. Nussenblatt R. B., Caspi R. R., Mahdi R. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-Antigen. J Immunol. 144:1990;1689-1695.
47. Zhang Z. J., Davidson L., Eisenbarth G., Weiner H. L. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA. 88:1991;10252-10256.
48. Sayegh M. H., Khoury S. J., Hancock W. H., Weiner H. L. Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat. Proc Natl Acad Sci USA. 89:1992;7762-7766.
49. Sayegh M. H., Zhang Z. J., Hancock W. H., Kwok C. A., Carpenter C. B., Weiner H. L. Down-regulation of the immune response to histocompatibility antigen and prevention of sensitization by skin allografts by orally administered alloantigen. Transplantation. 53:1992;163-166.
50. Weiner H. L., Mackin G. A., Matsui M. Doubled-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science. 259:1993;1321-1324.
51. Wang Z. Y., Qiao J., Link H. Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor. J Neuroimmunol. 44:1993;209-214.
52. Miller A., Lider O., Roberts A. B., Sporn M. B., Weiner H. L. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor B after antigen-specific triggering. Proc Natl Acad Sci USA. 89:1992;421-425.